Last Updated on December 11, 2024 by The Health Master
Revised Schedule M
The Indian pharmaceutical industry, particularly Micro, Small, and Medium Enterprises (MSMEs), is actively embracing the Revised Schedule M guidelines.
This proactive approach aims to elevate the quality standards of domestic drug manufacturing to international levels.
Key Focus Areas for Indian Pharma MSMEs
Indian pharma MSMEs are focusing on several key areas to implement the Revised Schedule M:
- Robust Pharmaceutical Quality System (PQS): Establishing a comprehensive PQS is essential to ensure consistent product quality.
- Quality Risk Management (QRM): Implementing QRM helps identify, assess, and control potential quality risks.
- Product Quality Reviews (PQR): Conducting regular PQRs enables continuous improvement in product quality.
- Computerized Storage Systems: Adopting advanced computerized systems for drug storage enhances efficiency and traceability.
CDSCO-IDMA Workshop Highlights the Path Forward
A recent workshop organized by the Central Drugs Standard Control Organization (CDSCO) in collaboration with the Food and Drug Control Administration (FDCA), Gujarat, and the Indian Drug Manufacturers Association (IDMA) shed light on the industry’s commitment to regulatory compliance.
Key Takeaways from the Workshop:
- Vendor Validation and Audit: Ensuring that suppliers adhere to stringent quality standards is crucial.
- Best Practices for GMP Compliance: Industry experts shared insights on effective strategies to meet GMP requirements.
- Alignment with Regulatory Framework: Understanding and complying with the latest regulatory guidelines is essential.
Revised Schedule M: A Catalyst for Global Recognition
The Revised Schedule M mandates several key changes, including:
- Comprehensive Validation Processes: Rigorous validation of equipment and processes is necessary to ensure product quality and consistency.
- Enhanced Supply Chain Quality: Stricter controls on the supply chain will help maintain product integrity.
A Collaborative Effort for a Brighter Future
Dr. H.G. Koshia, Commissioner of Gujarat FDCA, emphasized the importance of industry-regulatory collaboration.
He highlighted that such initiatives are crucial to drive the Indian pharmaceutical industry towards global excellence.
By embracing these changes, Indian pharma MSMEs can position themselves as reliable suppliers of high-quality drugs to the global market.
-
What is Revised Schedule M?
Revised Schedule M is a set of guidelines for Good Manufacturing Practices (GMP) in India. It outlines the quality standards that pharmaceutical manufacturers must adhere to.
-
Why is Revised Schedule M important?
Revised Schedule M is essential for ensuring the quality, safety, and efficacy of drugs manufactured in India. It also helps India align with international regulatory standards.
-
How can Indian pharma MSMEs implement Revised Schedule M?
Indian pharma MSMEs can implement Revised Schedule M by focusing on key areas such as PQS, QRM, PQR, and computerized storage systems. They should also collaborate with regulatory authorities and industry experts to stay updated on the latest guidelines and best practices.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Key Notes on Revised Schedule M: Must read
Important short notes for Industry and Regulators
CDSCO Guidelines on Drug Recall
Quality Assurance Vs Quality Control in the Pharma Industry
Major FDA audit findings about Equipment and Instruments
Understanding GMP, cGMP, and WHO-GMP
Quality Assurance in the Pharmaceutical Industry
Duties and responsibilities of QA person in Pharma Industry
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
Revised Schedule M to Take Effect from New Year: DCGI
Navigating the Revised Schedule M: A Deep Dive into Vendor Validation and Audit
Gujarat FDCA empowers Officers to enforce Revised Schedule M
Pharma Industry seeks more time to implement Revised Schedule M
Revised Schedule M: Discussion on Quality Risk Management
Schedule M: Over 100 Pharma MSMEs in Telangana on the Brink of Closure
CDSCO Panel approval granted for Anti Cancer Drug Pertuzumab
India drops Anti Dumping probe on Mono Ethylene Glycol
Kerala Drug Control Department Goes Digital: A New Era of Efficiency
NPPA’s ceiling price for Methylprednisolone Upheld
Hospital caught overcharging for Medicines: Hyderabad
Standards for 214 Critical Medical Devices to be developed
FDA Maharashtra cracks down on 15 Medical Stores
Ceiling Price for Acyclovir 800 mg Tablets upheld
Strengthening drug security through Pharmaceutical Supply Chain
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
